UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 374

Sortiert nach

Dynamic antibody responses to the Mycobacterium tuberculosis proteome

Proceedings of the National Academy of Sciences - PNAS, 2010-08, Vol.107 (33), p.14703-14708

2010

Volltextzugriff (PDF)

Proteome-Scale Antibody Responses and Outcome of Mycobacterium tuberculosis Infection in Nonhuman Primates and in Tuberculosis Patients

The Journal of infectious diseases, 2012-09, Vol.206 (5), p.697-705

2012

Volltextzugriff (PDF)

Evaluation of Antigens for Development of a Serological Test for Human African Trypanosomiasis

PloS one, 2016-12, Vol.11 (12), p.e0168074-e0168074

2016

Volltextzugriff (PDF)

Validation of Mycobacterium tuberculosis Rv1681 Protein as a Diagnostic Marker of Active Pulmonary Tuberculosis

Journal of Clinical Microbiology, 2013-05, Vol.51 (5), p.1367-1373

2013

Volltextzugriff (PDF)

Discerning Trends in Multiplex Immunoassay Technology with Potential for Resource-Limited Settings

Clinical chemistry (Baltimore, Md.), 2012-04, Vol.58 (4), p.690-698

2012

Volltextzugriff (PDF)

Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in mice

EMBO molecular medicine, 2012-01, Vol.4 (1), p.27-37

2012

Volltextzugriff (PDF)

Analytical sensitivity limits for lateral flow immunoassays

Clinical chemistry (Baltimore, Md.), 2008-07, Vol.54 (7), p.1250-1251

2008

Volltextzugriff (PDF)

Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing

Journal of clinical microbiology, 2018-06, Vol.56 (6)

2018

Volltextzugriff (PDF)

Systematic reference sample generation for multiplexed serological assays

Scientific reports, 2013-11, Vol.3 (1), p.3259-3259, Article 3259

2013

Volltextzugriff (PDF)

Ion Torrent next generation sequencing for accurate genotyping and detection of resistance associated variants in HCV and HIV: Presentation at ESCV 2016: Poster 47

Journal of clinical virology, 2016-09, Vol.82, p.S44-S45

2016

Volltextzugriff (PDF)

Ion Torrent next generation sequencing for accurate genotyping and detection of resistance associated variants in HCV and HIV

Journal of clinical virology, 2016-09, Vol.82, p.S44-S45

2016

Volltextzugriff (PDF)

Single-Molecule Detection on a Protein-Array Assay Platform for the Exposure of a Tuberculosis Antigen

Journal of proteome research, 2011-03, Vol.10 (3), p.1316-1322

2011

Volltextzugriff (PDF)

A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative HBeAg or HBV DNA levels

Antiviral therapy, 2008-01, Vol.13 (4), p.547-554

2008

Volltextzugriff (PDF)

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration

Journal of hepatology, 2007-04, Vol.46 (4), p.635-644

2007

Volltextzugriff (PDF)

Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects

Free radical biology & medicine, 2003-11, Vol.35 (10), p.1286-1292

2003

Volltextzugriff (PDF)

Multicenter Study of the LCxARG HIV RNA Quantitative Assay a a New Competitive Reverse Transcriptase-PCR which Targets pol Genomic Region of HIV-1 for the Measurement of Type B, Non-Type B and Group O HIV-1 RNA

Clinical chemistry and laboratory medicine, 2002-07, Vol.40 (7), p.698-704

2002

Volltextzugriff (PDF)

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administrations

Journal of hepatology, 2007, Vol.46 (4), p.635-644

2007

Volltextzugriff (PDF)

Anti-GOR and hepatitis C virus in autoimmune liver diseases

The Lancet (British edition), 1992-02, Vol.339 (8788), p.267-269

1992

Volltextzugriff (PDF)

Third Santorini conference pharmacogenomics workshop report: “Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?”

Clinical chemistry and laboratory medicine, 2007, Vol.45 (7), p.843-850

2007

Volltextzugriff (PDF)

Myosin Light Chain-Actin Interaction Regulates Cardiac Contractility

Circulation research, 1995-05, Vol.76 (5), p.720-725

1995

Volltextzugriff (PDF)

Third Santorini conference pharmacogenomics workshop report: aPharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?a

Clinical chemistry and laboratory medicine, 2007-07, Vol.45 (7), p.843-850

2007

Volltextzugriff (PDF)

Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection

Gastroenterology (New York, N.Y. 1943), 1995-02, Vol.108 (2), p.455-462

1995

Volltextzugriff (PDF)

In vivo models for drug discovery

1, 2014

Volltextzugriff (PDF)

Multicenter Study of the LCx® HIV RNA Quantitative Assay – a New Competitive Reverse Transcriptase-PCR which Targets pol Genomic Region of HIV-1 for the Measurement of Type B, Non-Type B and Group O HIV-1 RNA

Clinical chemistry and laboratory medicine, 2002-07, Vol.40 (7), p.698-704

2002

Volltextzugriff (PDF)

Significance of IgM anti-HCVcore level in chronic hepatitis C

Journal of hepatology, 1997-07, Vol.27 (1), p.36-41

1997

Volltextzugriff (PDF)

1 – 25 von 374

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(310)
Mit Volltextzugriff
(338)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Dynamic antibody responses to the Mycobacterium tuberculosis proteome

Proteome-Scale Antibody Responses and Outcome of Mycobacterium tuberculosis Infection in Nonhuman Primates and in Tuberculosis Patients

Evaluation of Antigens for Development of a Serological Test for Human African Trypanosomiasis

Validation of Mycobacterium tuberculosis Rv1681 Protein as a Diagnostic Marker of Active Pulmonary Tuberculosis

Discerning Trends in Multiplex Immunoassay Technology with Potential for Resource-Limited Settings

Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in mice

Analytical sensitivity limits for lateral flow immunoassays

Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing

Systematic reference sample generation for multiplexed serological assays

Ion Torrent next generation sequencing for accurate genotyping and detection of resistance associated variants in HCV and HIV: Presentation at ESCV 2016: Poster 47

Ion Torrent next generation sequencing for accurate genotyping and detection of resistance associated variants in HCV and HIV

Single-Molecule Detection on a Protein-Array Assay Platform for the Exposure of a Tuberculosis Antigen

A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative HBeAg or HBV DNA levels

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration

Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects

Multicenter Study of the LCxARG HIV RNA Quantitative Assay a a New Competitive Reverse Transcriptase-PCR which Targets pol Genomic Region of HIV-1 for the Measurement of Type B, Non-Type B and Group O HIV-1 RNA

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administrations

Anti-GOR and hepatitis C virus in autoimmune liver diseases

Third Santorini conference pharmacogenomics workshop report: “Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?”

Myosin Light Chain-Actin Interaction Regulates Cardiac Contractility

Third Santorini conference pharmacogenomics workshop report: aPharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?a

Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection

In vivo models for drug discovery

Multicenter Study of the LCx® HIV RNA Quantitative Assay – a New Competitive Reverse Transcriptase-PCR which Targets pol Genomic Region of HIV-1 for the Measurement of Type B, Non-Type B and Group O HIV-1 RNA

Significance of IgM anti-HCVcore level in chronic hepatitis C

Suchergebnisse filtern